Pinned post
The FDA has approved belzutifan for the treatment of advanced renal cell carcinoma- a first-in-class drug discovered and developed by UTSW researchers over three decades.
bit.ly/BelzutifanAppr…
@UTSWNews @utswcancer @UTSWInternalMed
bit.ly/BelzutifanAppr…
@UTSWNews @utswcancer @UTSWInternalMed